Arkolith/Insider Trading/PRAH/Form 4

Gaenzle Christopher L

EVP, CAO & General CounselPRA Health Sciences, Inc. (PRAH) · full profile →Form 4 · filed Jun 21, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.6M
Net Open-Market Flow
-$4.6M
Transactions
10
7 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2021Sell(S)13K$168.06$2.3M47K
Jun 17, 2021Sell(S)12K$169.41$2.1M35K
Jun 17, 2021Sell(S)1K$167.40$218K61K
Jun 17, 2021Option exercise(M)4K$103.30$447K62K
Jun 17, 2021Sell(S)692$169.75$117K35K
Jun 17, 2021Option exercise(M)4K$95.94$404K39K
Jun 17, 2021Option exercise(M)19K$101.42$1.9M58K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2021Option exercise(M)4K—$017K
Jun 17, 2021Option exercise(M)4K—$017K
Jun 17, 2021Option exercise(M)19K—$038K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-083613) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML